Article Details

Innovent Releases Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with ...

Retrieved on: 2020-11-23 00:00:00

Tags for this article:

Click the tags to see associated articles and topics

Innovent Releases Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with .... View article details on hiswai:

Excerpt

ORIENT-32 is the first randomized Phase 3 study reporting the efficacy and safety of an anti-PD-1 <b>antibody</b>-based combination therapy versus ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo